Steve Pacelli Appointed CEO of Epitel, Inc.
Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of Growth
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States
Epitel Publication accepted for Special Edition of Frontiers Neurology
Epitel’s second publication has been accepted for publication in a special edition of Frontiers Neurology.